Grünwald, 14 March 2025 – Dermapharm Holding SE ("Dermapharm"), an innovative and rapidly growing manufacturer of branded pharmaceuticals and other healthcare products, today published its unaudited ...
Icon PLC (NASDAQ:ICLR) anticipates that pass-through revenue mix will increase in the first half of 2025, which will pressure EBITDA margins. Q: Can you discuss the demand environment and how that ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback